Strong organic growth in high-margin "Branded pharmaceuticals" and revenue growth in "Parallel import business" segment more than offset slight decline in revenue from "Other healthcare products" ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback